{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:58:55Z","timestamp":1780066735320,"version":"3.54.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA179715"],"award-info":[{"award-number":["U01 CA179715"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 CA156733"],"award-info":[{"award-number":["U54 CA156733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA058223"],"award-info":[{"award-number":["P50 CA058223"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA151135"],"award-info":[{"award-number":["P01 CA151135"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32 ES007018"],"award-info":[{"award-number":["T32 ES007018"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13058-017-0914-6","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T12:41:59Z","timestamp":1512996119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-8577","authenticated-orcid":false,"suffix":"Jr","given":"Humberto","family":"Parada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie M.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ClarLynda R.","family":"Williams-DeVane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea T.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Perou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Olshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Troester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"914_CR1","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJMsr070105","volume":"356","author":"PM Ravdin","year":"2007","unstructured":"Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670\u20134.","journal-title":"N Engl J Med"},{"key":"914_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3322\/canjclin.56.3.168","volume":"56","author":"C Smigal","year":"2006","unstructured":"Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168\u201383.","journal-title":"CA Cancer J Clin"},{"key":"914_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3322\/caac.21271","volume":"65","author":"B Daly","year":"2015","unstructured":"Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65:221\u201338.","journal-title":"CA Cancer J Clin"},{"key":"914_CR4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492\u2013502.","journal-title":"JAMA"},{"key":"914_CR5","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","volume":"16","author":"KM O\u2019Brien","year":"2010","unstructured":"O\u2019Brien KM, Cole SR, Tse C-K, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010;16:6100\u201310.","journal-title":"Clin Cancer Res"},{"key":"914_CR6","doi-asserted-by":"publisher","first-page":"djx135","DOI":"10.1093\/jnci\/djx135","volume":"110","author":"MA Troester","year":"2018","unstructured":"Troester MA, Sun X, Allott EH, Geradts J, Cohen SM, Tse C-K, et al. Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst. 2018;110:djx135.","journal-title":"J Natl Cancer Inst"},{"key":"914_CR7","first-page":"689","volume":"144","author":"D Huo","year":"2017","unstructured":"Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, et al. Comparison of breast cancer molecular features and survival by African and European ancestry in the Cancer Genome Atlas. JAMA Oncol. 2017;144:689\u201399.","journal-title":"JAMA Oncol"},{"key":"914_CR8","doi-asserted-by":"publisher","first-page":"e82460","DOI":"10.1371\/journal.pone.0082460","volume":"8","author":"PA Stewart","year":"2013","unstructured":"Stewart PA, Luks J, Roycik MD, Sang Q-XA, Zhang J. Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer. PLoS One. 2013;8:e82460.","journal-title":"PLoS One"},{"key":"914_CR9","doi-asserted-by":"publisher","first-page":"e4531","DOI":"10.1371\/journal.pone.0004531","volume":"4","author":"DN Martin","year":"2009","unstructured":"Martin DN, Boersma BJ, Yi M, Reimers M, Howe TM, Yfantis HG, et al. Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One. 2009;4:e4531.","journal-title":"PLoS One"},{"key":"914_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/1756-0500-5-248","volume":"5","author":"JM Grunda","year":"2012","unstructured":"Grunda JM, Steg AD, He Q, Steciuk MR, Byan-Parker S, Johnson MR, et al. Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American women diagnosed with breast cancer. BMC Res Notes. 2012;5:248.","journal-title":"BMC Res Notes"},{"key":"914_CR11","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/cncr.26405","volume":"118","author":"LA Field","year":"2012","unstructured":"Field LA, Love B, Deyarmin B, Hooke JA, Shriver CD, Ellsworth RE. Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer. 2012;118:1334\u201344.","journal-title":"Cancer"},{"key":"914_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10549-015-3474-4","volume":"152","author":"M D\u2019Arcy","year":"2015","unstructured":"D\u2019Arcy M, Fleming J, Robinson WR, Kirk EL, Perou CM, Troester MA. Race-associated biological differences among luminal A breast tumors. Breast Cancer Res Treat. 2015;152:437\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"914_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00694745","volume":"35","author":"B Newman","year":"1995","unstructured":"Newman B, Moorman PG, Millikan R, Qaqish BF, Geradts J, Aldrich TE, et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat. 1995;35:51\u201360.","journal-title":"Breast Cancer Res Treat"},{"key":"914_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317\u201325.","journal-title":"Nat Biotechnol"},{"key":"914_CR15","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160\u20137.","journal-title":"J Clin Oncol"},{"key":"914_CR16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/modpathol.3800445","volume":"18","author":"EA Rakha","year":"2005","unstructured":"Rakha EA, Boyce RWG, Abd El-Rehim D, Kurien T, Green AR, Paish EC, et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol. 2005;18:1295\u2013304.","journal-title":"Mod Pathol"},{"key":"914_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1091\/mbc.7.4.565","volume":"7","author":"J Wesseling","year":"1996","unstructured":"Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin\/MUC1. Mol Biol Cell. 1996;7:565\u201377.","journal-title":"Mol Biol Cell"},{"key":"914_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.molcel.2005.11.030","volume":"21","author":"X Wei","year":"2006","unstructured":"Wei X, Xu H, Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor \u03b1. Mol Cell. 2006;21:295\u2013305.","journal-title":"Mol Cell"},{"key":"914_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2156-15-38","volume":"15","author":"S Rummel","year":"2014","unstructured":"Rummel S, Penatzer CE, Shriver CD, Ellsworth RE. PSPHL and breast cancer in African American women: causative gene or population stratification? BMC Genet. 2014;15:1\u201311.","journal-title":"BMC Genet"},{"key":"914_CR20","doi-asserted-by":"publisher","first-page":"19435","DOI":"10.1038\/srep19435","volume":"6","author":"DN Brown","year":"2016","unstructured":"Brown DN, Caffa I, Cirmena G, Piras D, Garuti A, Gallo M, et al. Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer. Sci Rep. 2016;6:19435.","journal-title":"Sci Rep"},{"key":"914_CR21","unstructured":"NCBI. SQLE squalene epoxidase [Homo sapiens (human)]. 2017. \n                    https:\/\/www.ncbi.nlm.nih.gov\/gene\/6713\n                    \n                  . Accessed 1 Jan 2017."},{"key":"914_CR22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1241908","volume":"342","author":"ER Nelson","year":"2013","unstructured":"Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science (80-). 2013;342:1094\u20138.","journal-title":"Science (80-)"},{"key":"914_CR23","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/0140-6736(92)90744-N","volume":"339","author":"H Buchwald","year":"1992","unstructured":"Buchwald H. Cholesterol inhibition, cancer, and chemotherapy. Lancet. 1992;339:1154\u20136.","journal-title":"Lancet"},{"key":"914_CR24","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/S1470-2045(14)70119-6","volume":"15","author":"TP Ahern","year":"2014","unstructured":"Ahern TP, Lash TL, Damkier P, Christiansen PM, Cronin-Fenton DP. Statins and breast cancer prognosis: evidence and opportunities. Lancet Oncol. 2014;15:e461\u20138.","journal-title":"Lancet Oncol"},{"key":"914_CR25","unstructured":"NCBI. FAM177A1 family with sequence similarity 177 member A1 [Homo sapiens (human)]. 2017. \n                    https:\/\/www.ncbi.nlm.nih.gov\/gene\/283635\n                    \n                  . Accessed 1 Jan 2017."},{"key":"914_CR26","unstructured":"NCBI. PSPHP1 phosphoserine phosphatase pseudogene 1 [Homo sapiens (human)]. 2017. \n                    https:\/\/www.ncbi.nlm.nih.gov\/gene\/8781\n                    \n                  . Accessed 1 Jan 2017."},{"key":"914_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0378-1119(98)00083-3","volume":"210","author":"SA Planitzer","year":"1998","unstructured":"Planitzer SA, Machl AW, Rueckels M, Kubbies M. Identification of a novel c-DNA overexpressed in Fanconi\u2019s anemia fibroblasts partially homologous to a putative L-3-phosphoserine-phosphatase. Gene. 1998;210:297\u2013306.","journal-title":"Gene"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-017-0914-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-017-0914-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-017-0914-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:34:40Z","timestamp":1589549680000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-017-0914-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1186\/s13058-017-0914-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"16 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the University of North Carolina (UNC, Chapel Hill, NC). All participants gave informed consent before they entered the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CMP is an equity stock holder, and Board of Director Member, of BioClassifier LLC and GeneCentric Diagnostics. CMP is also listed as an inventor on a patent application for the PAM50 assay. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"131"}}